Access+
The innovation was the hard part. The access should be easy.
High-performance therapies require high-performance delivery. Access+ is a connected hub experience designed to accelerate your therapy’s path from prescription to treatment.
Contact sales
Introducing Access+, the High-Performance Gateway for Your Innovation
Access+ is built to ensure your therapy’s momentum never stalls. We replace fragmented processes with a unified infrastructure to remove the barriers between the prescription and the patient.
With a 1.5-day target speed-to-therapy and a 75% average conversion rate, we ensure the first step toward care is as precisely engineered as the medicine itself—protecting your brand’s integrity and commercial potential every step of the way.
Access+ Performance Standards
1.5 days
Target speed to therapy
From prescription to patient door vs. 7–14 day industry average.
75%
Avg. NRx Conversion
Proven performance on active partner programs; balancing affordability with access to protect your brand’s potential.
81
NPS & 90% Service Satisfaction
A consumer-grade experience that honors your mission and supports the patient every step of the way.
+
Maximized GTN Efficiency
Automated eligibility and real-time copay checks to reduce manufacturer leakage.
The Fuze Difference: A Unified Alternative
Where traditional models rely on manual processes and digital-only players offer fragmented point solutions, Access+ provides a unified alternative.
Rapid Intake-to-Access
eRx are processed in minutes with AI-assisted verification and automated eligibility across referral types. 80% of referrals processed within <1 business day and 99% processed within 2 business days.
End-to-End PA Automation
We don't just track PAs; we automatically initiate and manage the full lifecycle, from pre-populated submissions to configurable provider and payer follow-up. When a decision is reached, automated routing advances the next step: approval, bridge fill, or an alternative path forward.
White-Labeled in Weeks
A fully branded experience—from the NPI to the patient UX—deployed in weeks. Maintain visibility even when third-party pharmacies dispense.
A Unified
Ecosystem
A singular platform designed to fuse community, testing and medication delivery—supporting the entire patient lifecycle under one white-labeled brand.
The science is ready. Now, the access is, too.
If you’re exploring ways to streamline the path from innovation to patient, let’s talk. Our team is ready to help you set a new standard in motion.
FuzeRx Hayward
In accordance with the Controlled Substances Act and the DEA regulations, this online pharmacy has made the notifications to the DEA Administrator required by 21 U.S.C. 831 and 21 CFR 1304.40. FuzeRx Hayward complies with the requirements of section 311 of the Act (21 U.S.C. 831) with respect to the delivery or sale or offer for sale of controlled substances. For more information, review the Internet Pharmacy Site Disclosure.
All trademarks are the property of their respective owners, are used with permission, and may be registered in one or more jurisdictions.
©2026 Fuze Corporate Inc., All Rights Reserved